Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF TrialCirculation 2019 Nov 17;[EPub Ahead of Print], MN Kosiborod, P Jhund, KF Docherty, M Diez, MC Petrie, S Verma, JC Nicolau, B Merkely, M Kitakaze, DL DeMets, SE Inzucchi, L Køeber, FA Martinez, P Ponikowski, MS Sabatine, SD Solomon, O Bengtsson, D Lindholm, A Niklasson, M Sjöstrand, AM Langkilde, JJV McMurray
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.